Responses
Clinical pharmacy and clinical trials (including case series)
CPC-003 A Retrospective Analysis of the Switches from Originator and Biosimilar Recombinant Human Erythropoietins in Chronic Kidney Disease
Compose a Response to This Article
Other responses
No responses have been published for this article.